MediGene medigene.de


Public list: BIO 2016 (619) Medical Devices (6123)

Medigene is a publicly listed (Frankfurt: MDG1, prime standard) biotechnology company headquartered in Martinsried near Munich, Germany. Medigene focuses on clinical research and development of novel drugs against cancer and autoimmune diseases. Medigene is the first German biotech company to have revenues from a marketed product, Veregen, which is distributed by commercial partners companies. Medigene has two drug candidates in clinical trials, EndoTAG-1 and RhuDex, and is developing an innovat...Show all

Medigene is a publicly listed (Frankfurt: MDG1, prime standard) biotechnology company headquartered in Martinsried near Munich, Germany. Medigene focuses on clinical research and development of novel drugs against cancer and autoimmune diseases. Medi...Show all

Company (IPO / Went public)

Phone: +49-89-85 65-29 00

Fax: +49-89-85 65-29 20

Lochhamer Str. 11

Planegg-Martinsried, D-82152
Germany

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
MediGene $102.5M Jun 2, 2000
See all 15 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related MediGene Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 2 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors
See all 15 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Method of administering a cationic liposomal preparation Dec 04, 2015 Nov 28, 2017 Patent
Anti-her2 vaccine based upon aav derived multimeric structures Sep 14, 2012 Nov 21, 2017 Patent
Medicament for the treatment of viral skin and tumour diseases Sep 21, 2010 Sep 26, 2017 Patent
Treatment of breast cancer Aug 24, 2015 Jul 18, 2017 Patent
Mutated structural protein of a parvovirus Oct 11, 2012 Apr 18, 2017 Patent
See all 29 patents